Introduction
Patient adherence to medication therapy is essential for the control of coronary artery disease (CAD) and prevention of its complications (1) , constituting one of the biggest challenges for the nursing care to coronary disease patients, given the high percentage of nonadherence to the therapeutic medication regimen (2) . This construct refers to the extent to which patients follow the instructions of their physician or other healthcare professionals (3) . It is a complex phenomenon influenced by a range of factors, including, individual beliefs, skills, financial resources and/or barriers, and social influences (3) . Among the causes of non-adherence, the need for continued treatment can be highlighted, as well as the perceived lack of immediate benefits, the potential for adverse effects, and the costs associated with the treatment (3) .
Medication adherence can have significant
impact on the health-related quality of life (HRQoL) in patients with chronic clinical conditions (4) (5) , including CAD (6) . Although they are different constructs, adherence and HRQoL are related to patients and should be considered when evaluating the impact of interventions that affect their health (7) .
Furthermore, these constructs are considered distinct outcomes in the care process -while adherence constitutes an intermediate result, HRQoL can be understood as a final outcome of the treatment (7) . Thus, it is possible to assume that interventions outlined for optimizing adherence influence medication adherence a priori and subsequently the HRQoL.
Although targeted at different health conditions, some studies have investigated the relationship between HRQoL and adherence. Among these, cross-sectional studies with geriatric hypertensive patients (5) , the use of medication for treatment of acquired immunodeficiency syndrome (8) and treatment with lipid-lowering drugs (9) can be highlighted. A recent literature review showed that few longitudinal studies have evaluated the impact of a theory-based intervention for the promotion or optimization of medication adherence on the general and specific HRQoL of patients with chronic (10) 
Methods

Subjects and Procedures
Data from this study are derived from a broader experimental study (11) 
Sample
After the acceptance of the invitation to participate in the study and provision of the formal consent by signing the Terms of Informed Consent, the subjects were randomized into control group (CG) or intervention group (IG). The aleatorization was based on a random sequence list generated by the SAS, version 9. The patients of the IG were submitted to the planning strategies -Action Planning and Coping Planning, applied by the main researcher; while the patients in the CG received usual care.
Data Collection
Data were gathered from June 2010 to May 2011, using structured interviews and consultation of the hospital medical records at two different times:
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-T 0 (baseline): interview and consent of the patient to participate in the study obtained by signing the term. Data related to sociodemographic and clinical characterization, medication adherence (12) , factors related to non-adherence (13) and general and specific (15) HRQoL (14) were obtained; -T 2 (two months after T 0 ): adherence and HRQoL measures were again obtained.
Intervention
The intervention was applied at T 0 with only those patients in the IG and consisted of the formulation and implementation of plans, according to the theoretical assumptions of Implementation Intention (16) (17) , based on a previous Brazilian study (18) . Patients were asked to design, in conjunction with the researcher, action and coping plans related to medication adherence. At T 1 (one month after T 0 ) presential reinforcement of the planning strategies was performed, by reading together the plans prepared at T 0. The details of the intervention can be found in a previous study (11) .
Control
The patients allocated to the CG received the routine care of the unit, which consisted of the usual clinical monitoring performed at the outpatient clinic.
They were instructed to maintain their routine activities as well as their clinical follow-up appointments with the physician.
Instruments
-The Morisky Self-Reported Measure of Medication Adherence Scale (13) : composed of four questions relating to non-adherence to pharmacological treatment, structured in Likert-type scales with four or five answer choices, the sum of which generates a score ranging from 4 up to 18; the lower the score the higher the favorability to adherence.
-Proportion of medication adherence (Proporção de adesão medicamentosa) (12) : constructed to identify Those who obtained a percentage of consumption of prescribed medications, equal to or greater than 80% (20) were considered "Adherent". For those who used more than one medication, the proportion of adherence was calculated through the mean of the percentages of adherence to each medication (12) . The proportion of adherence was analyzed as a continuous and binary variable -appropriate dose (dose used ≥80% of the prescribed dose) and inappropriate dose (dose <80% of the prescribed dose).
-Overall adherence assessment: the number and frequency of medications taken were evaluated, as well as their association with temporal markers:
fasting, breakfast, lunch and dinner. This was evaluated based on the following classification: Group I (appropriate dosage and care for the prescription);
Group II (appropriate dosage and inappropriate care),
Group III (inappropriate dosage and appropriate care) and Group IV (inappropriate dosage and care).
The patients classified in group I were considered "Adherent", and those classified in groups II, III, and IV "Non-adherent" (12) .
-The MacNew Heart Disease Health-related Quality of is completely missing (22) . The Brazilian version of MacNew (15) is considered reliable, valid and simple to apply (15, 23) . In the present study the reliability with respect to the internal consistency, assessed through
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Cronbach's alpha coefficient, ranged between 0.80 and 0.90 throughout the monitoring.
-The 36-item Short Form Health Survey -SF-36: is a generic evaluation instrument of the perceived health status (24) , which is easy to administer and comprehend. It consists of eight domains: Functional Capacity (ten items), Physical Aspects (four items), Pain (two items), General
Health Status (five items), Vitality (four items), Social
Aspects (two items), Emotional Aspects (three items),
Mental Health (five items), and one question comparing the current health conditions with those of one year previous.
The final score ranges from zero (worst health status) up to 100 (best health status)
.
The Brazilian version of the SF-36 (14) was used and, in the present study, the internal consistency, assessed through Cronbach's alpha coefficient, ranged between 0.80 and 0.90 throughout the monitoring.
Data Analysis
Descriptive analyzes were performed to characterize the sample according to sociodemographic, clinical, . The significance level adopted for the statistical tests was p ≤ 0.05.
Ethical Aspects
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that were adherent, when using the overall evaluation of adherence measure (p=0.023) ( Table 1) .
Analysis of Health Related Quality of Life (HRQoL) measures
Regarding the specific HRQoL (MacNew), significantly higher mean scores (p<0.05) for all domains of the MacNew were observed in the IG at T 2 , when compared to the baseline (T 0 ). However, a significant increase in the scores of the majority of the MacNew domains was also observed in the CG, except in the emotional functioning domain, however, these differences were not statistically significant ( Aspects (p<0.05) domains, when compared to the scores obtained at T 0 . In the CG no significant differences were observed between the scores obtained at T 2 and T 0 .
While the intervention explained 5% of the variability of the proportion of adherence measure (11) , the linear regression analysis showed that the Intervention was not able to explain the variability of the general and specific HRQoL measures.
Relationship between Adherence and Health Related
Quality of Life
Regarding the correlations between the Morisky scale scores and those of the specific HRQoL, the absence of correlations was found in the IG, at T 0 .
However, at T 2 , low magnitude negative correlations With regard to the relationship between the proportion of adherence and the general HRQoL 
Discussion
This study aimed to compare the general and specific The exact mechanism by which medication adherence is associated with HRQoL is still unknown, with suggestions that HRQoL is part of a complex network of psychosocial characteristics that influence the patient's ability to cope with the chronicity of the disease (5) .
Previous findings (4) involving type 2 diabetic patients showed that medication adherence was not associated with the HRQoL domains. However, an association was observed with the combination of knowledge about the medical prescription and the attitude toward medication adherence, indicating the need for research into the determinant psychosocial variables for adherence behavior.
The absence or weak relationship between adherence and HRQoL were observed in other studies using self-reported measures (6) as well as those using electronic records of prescriptions (4, 8) .
Thus, our results 
Conclusion
The findings indicate that the intervention based 
